These experiments additionally showed the genetic organization of the SLT-II genes to be the same as that of the SLT-I genes, with the coding sequence for the large A subunit adjacent to that for the smaller B subunit. The mobilities of the SLT-II subunits in sodium dodecyl sulfate-polyacrylamide gels were slightly greater than those determined for the SLT-I subunits. Although apparent processing of the SLT-I subuhits was observed with polymyxin B treatment of the labeled minicells, no processing of the SLT-II subunits was detected. Southern [885][886] 1985). SLT-I is structurally similar to Shiga toxin, containing an A subunit and multiple B subunits (26, 30) . Some of these E. coli strains produce moderate levels (103 to 104 50% cytotoxic doses per ml of sonic lysate) of a cell-associated cytotoxin that is not neutralized by antibody to Shiga toxin but apparently shares DNA homology and functional activity with 20, 28, 35 (14) .
A number of Escherichia coli strains isolated from cases of enteropathogenic diarrhea, enterohemorrhagic colitis, and hemolytic uremic syndrome are associated with production of cytotoxins which exhibit biological activities characteristic of Shigella dysenteriae type 1 (Shiga) toxin (4) . Some of these E. coli strains produce high levels (105 to 108 50% cytotoxic doses per ml of sonic lysate) of a cell-associated cytotoxin that is neutralized by antibodies against Shiga toxin (5, 16, 20, 28 ; A. D. O'Brien, T. A. Lively, T. W. Chang, and S. W. Gorbach, Lancet ii: 573, 1983 ). This toxin has been designated Shiga-like toxin type I (SLT-I) (35) or Vero cell toxin type 1 (VT1) (16; S. M. Scotland, H. R. Smith, and B. Rowe, Lancet ii: [885] [886] 1985) . SLT-I is structurally similar to Shiga toxin, containing an A subunit and multiple B subunits (26, 30) . Some of these E. coli strains produce moderate levels (103 to 104 50% cytotoxic doses per ml of sonic lysate) of a cell-associated cytotoxin that is not neutralized by antibody to Shiga toxin but apparently shares DNA homology and functional activity with SLT-I (5, 20, 28, 35) . This cytotoxin has been designated Shiga-like toxin type II (SLT-II) (35) or Vero cell toxin type 2 (VT2) (S. M. Scotland, H. R. Smith, and B. Rowe, Lancet ii: [885] [886] 1985) .
Production of SLT-I and SLT-II in some E. coli strains is associated with lysogenic toxin-converting bacteriophages (29, 32, 35 ; H. R. Smith 216, 1983 ). In the hemorrhagic colitis-associated E. coli 0157:H7 strain 933, both toxin types are produced (29) . Two bacteriophages, 933J and 933W, control expression of the SLT-I and SLT-II cytotoxins, respectively (35) . In contrast, other E. coli isolates have been described which produce only SLT-I or SLT-II (20) . Previous cloning (23) and sequence analysis (15) of the structural genes for SLT-I identified two subunits: an A subunit and a smaller B subunit with predicted molecular weights for the mature proteins of * Corresponding author. 32 ,211 and 7,690. The subunit structural genes, slt-I A and slt-I B, are on a single transcriptional unit with the A subunit gene preceding the B subunit gene and with each subunit apparently possessing its own putative ribosome-binding site and signal peptides (15, 23) . The 933J SLT-I genes appear to be identical to the recently described SLT-I structural genes cloned from the closely related bacteriophage H19B isolated from the enteropathogenic E. coli H19 (14) .
Although the cytotoxicity of sonic lysates from bacteria encoding only SLT-II is significantly less than that of strains synthesizing only SLT-I, the production of either toxin alone has been associated with pathogenesis. An important question with respect to the pathogenicity of these E. coli isolates remains, that is, whether the SLT-I and SLT-II toxins represent the same potential pathogenic mechanism or two distinct mechanisms mediated by two different toxins. The purpose of this investigation was to begin to address this question by isolating and characterizing the genes for SLT-II production from phage 933W and then comparing their genetic organization and gene products with those of the SLT-I genes previously described for phage 933J.
MATERIALS AND METHODS
Bacterial strains, bacteriophage, and plasmids. The toxinconverting phage 933W (29, 35) used in this study was obtained from a mitomycin C-induced phage lysate of the hemorrhagic colitis-associated E. coli 0157:H7 strain 933 (29) . E. coli 395-1(933W) was constructed by lysogenizing E. coli 395-1 (13) with phage 933W. E. coli C600 (1) and S. dysenteriae type 1 strain 60R (27) have been described previously. E. coli HB101 (3) was used as the recipient in transformation and as the host for the recombinant plasmids. The E. coli K-12 minicell-producing strain was DS410 (8) . Plasmid vectors pUC18 (24) and pBR328 (33) were used for molecular cloning. Recombinant plasmid pJN25, an SLT-Ipositive clone derived from phage 933J, has been described previously (23) .
Medium and culture conditions. Luria-Bertani (LB) medium (21) Cytotoxicity and neutralization assays. E. coli H13101 (pNN76), E. coli C600(933W), and S. dysenteriae type 1 strain 60R were grown overnight at 37°C with shaking in iron-depleted glucose syncase broth (28) . The cultures were then diluted to an A600 of 0.03 in 50 ml of medium and further incubated for 24 h. The bacteria were harvested by centrifugation, the culture supernatants were collected, and cell lysates were prepared by sonic disruption by published procedures (25) with the exception that the bacteria were suspended in 3 ml of buffer before sonication. Cytotoxicity for HeLa cells was measured by the method of Gentry and Dalrymple (11) . Vero cells were also used in the cytotoxicity assay (35) . Sonic lysates were tested for neutralizable cytotoxin with rabbit antisera against crude phage 933W SLT-II (35) , purified Shiga toxin (27) , or a combination of both antisera (35) . The (31) . The NcoI-EcoRV restriction fragment of pJN25 (23) was used as the DNA probe. Southern hybridization with the SLT-II gene fragment between restriction sites PvuII and EcoRV (this study) was performed as previously described (34) . In both the colony blot and Southern hybridization procedures, the filters were incubated for 18 to 24 h in a hybridization solution containing labeled probe, 6x SSC (1 x SSC is 0.15 M sodium chloride plus 0.015 M sodium citrate), 5x Denhardt solution (18) , 0.25% sodium dodecyl sulfate, and 100 jig of sheared denatured salmon sperm DNA per ml. The colony blot hybridization was incubated at 60°C, and the Southern hybridization was incubated at 52°C. Filters were then washed twice in 6x SSC at 45°C, rinsed once in 1x SSC at room temperature, allowed to dry, and exposed to X-ray film (Eastman Kodak Co., Rochester, N.Y.) in the presence of intensifying screens. For conditions of high stringency, the hybridization solutions were incubated at 68°C overnight and the filters were washed in 0.1x SSC at 62°C.
Analysis of plasmid-encoded proteins in minicells. Plasmids containing selected subclones of the original 4.9-kilobase (kb) EcoRI fragment isolated in pNN76 were analyzed with E. coli K-12 minicells. Plasmid-encoded proteins were labeled with [35S]methionine in Tricine buffer (New England Nuclear Research Products) as previously described (22) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (17) and autoradiography (7) . Polymyxin B extraction (12) of the labeled proteins present in the periplasm was done immediately after radiolabeling of the minicells. A fivefold concentration of the labeled minicells was suspended in M9-methionine assay medium (9, 21) supplemented with 0.4 mg of polymyxin B per ml. The cells were then further incubated at 37°C for 30 min, and the supernatants were recovered after centrifugation to remove the cells.
RESULTS AND DISCUSSION
To isolate the genes controlling production of SLT-II from phage 933W, EcoRI fragments of phage 933W were cloned into the plasmid vector pBR328 and transformed into E. coli HB101. Digestion of phage 933W DNA produces approximately 12 EcoRI fragments. A set of 90 randomly selected transformants were tested by DNA colony blot hybridization to identify those recombinant clones containing phage 933W DNA fragments homologous to the SLT-I gene of phage 933J. The presence of homology between the SLT-I and SLT-II genes had been suggested in earlier studies (35, 37) . The probe for this hybridization screening was the NcoIEcoRV fragment of plasmid pJN25 (23) . This 3.1-kb DNA fragment contains a complete and functional copy of the SLT-I structural genes and the adjacent phage 933J DNA sequences. Only 2 of the 90 transformants tested hybridized with the NcoI-EcoRV DNA probe. All 90 transformants were tested for elevated toxin production. Only the two clones reacting with the SLT-I gene-containing NcoI-EcoRV fragment produced elevated levels of cytotoxic activity. These two clones contained the same 4.9-kb EcoRI DNA fragment. One toxin-producing recombinant plasmid, designated pNN76, was chosen for further study.
Total amounts of cytotoxic activity produced by E. coli HB101(pNN76) were compared with the levels made by the toxin reference strain S. dysenteriae 60R (8a) and by an E. coli K-12 lysogen of phage 933W (Table 1) . Strain HB101(pNN76) produced a sevenfold-greater level of cytotoxic activity than that of the phage 933W lysogen. A similar sevenfold increase in toxin activity relative to that of the corresponding phage lysogen was previously observed during the cloning of the SLT-I structural genes from phage 933J (23) . This increase is consistent with an increase in toxin gene copy number caused by the use of a multicopy cloning vector. Neutralization studies (Table 1) confirmed that the cytotoxic activity associated with recombinant plasmid pNN76 was that of SLT-II.
A restriction map of the 4.9-kb EcoRI fragment was determined (Fig. 1) . To define more precisely within this fragment the location of the nucleotide sequences associated with SLT-II activity, we constructed a series of subclones using the cloning vector pUC18. These subclones and their cytotoxic activity are depicted in Fig. 1 . Only subclones containing the contiguous segment of DNA between the KpnI and SphI restriction sites were positive for elevated levels of toxin activity. Attempts to reduce the KpnI-SphI insert to PstI-SphI (see pNN105, Fig. 1 ) or to KpnI-EcoRV (see pNN106, Fig. 1 ) resulted in the formation of toxinnegative subclones. These findings suggested that the interval between the PstI and the EcoRV sites represents a region internal to the complete DNA sequence controlling SLT-II synthesis.
Next, using E. coli minicells, we characterized the products from SLT-II-related DNA sequences and compared these products with those of the SLT-I structural genes. In addition to comparing polypeptide sizes, we wished to determine whether processing of the subunits could be detected. Analysis of the DNA sequence of SLT-I led to a prediction that both A and B subunits contain amino acid leader sequences (15) . These should be removed during transport to the periplasm. A comparison between the sizes of the subunits present in polymyxin B-derived periplasmic extracts with those present in whole-cell lysates of SLTp N N 7 producing minicells would enable us to verify this prediction. Any similarities in the properties of the SLT-I and SLT-II products would further help to define the relationship between the two toxins and provide evidence that phage 933W encodes the structural genes for SLT-II. For these experiments, E. coli minicells were prepared containing either SLT-II subclone pNN103, pNN104, or pNN108 or SLT-I clone pJN25 (23) . Before conducting the minicell analysis, we wanted to eliminate expression of those vector-encoded gene products with molecular weights similar to that of the A subunit of SLT-I. To achieve this, we recloned the insertions from each of the three SLT-II-related plasmids as EcoRI-PvuI fragments from pUC18 into pBR328. By using this comblnation of restriction sites, both the chloramphenicol and the ampicillin resistance genes of the pBR328 vector were insertionally inactivated. These constructions eliminated the plasmid-encoded gene products associated with these antibiotic resistances from appearing in the minicell analysis and more clearly demonstrated the polypeptides encoded by the cloned DNA fragments. To provide an appropriate vector control in which only tetracycline resistance was expressed, we deleted the Scal fragment of pBR328 (33) .
The analysis of plasmid-encoded proteins synthesized by minicells is shown in Fig. 2 . Each lane in Fig. 2 is labeled with the corresponding plasmid or cloned fragment which directed protein synthesis in the minicell sample. When done, treatment of a sample with polymyxin B is also indicated (+PB). The complete pBR328 vector produced four labeled bands: tetracycline resistance protein, ,Blactamase precursor, mature p-lactamase, and chloramphenicol acetyltransferase. The pBR328 vector containing the Scal deletion (see pBR328AScaI) produced only the tetra- cycline resistance protein. The other polypeptides associated with the ampicillin and chloramphenicol resistances were no longer expressed. The first lane is a polymyxin B extraction of complete pBR328 (see pBR328+PB). Under these conditions, neither the tetracycline resistance cytoplasmic membrane protein nor the ,B-lactamase precursor was recovered. Chloramphenicol transacetylase is a cytoplasmic protein made in large quantities in the cell. A small amount of this protein is apparently extracted under these conditions.
The products synthesized by the SLT-I clone used in this study have been previously characterized (23) . These proteins include an A subunit (32,500 molecular weight) and a B subunit (9,400 molecular weight) as determined from Fig. 2 . Like the SLT-I-positive (NcoI-EcoRV) clone, the SLT-IIpositive (KpnI-SphI) clone also directed synthesis of A (33,000 molecular weight) and B (9,800 molecular weight) subunits. These are indicated by arrowheads at the left of each lane in Fig. 2 . In the whole-cell lysate of the SLT-I clone, there were two different species of the B subunit present with molecular weights of 9,400 and 7,500. In contrast, only one SLT-II B-subunit polypeptide was seen. Based on these molecular weight estimates, the SLT-II A and B subunits appear slightly larger than the corresponding SLT-I subunits. Thus, the cloned SLT-II sequences direct synthesis of two polypeptides similar but not identical to the A and B subunits of SLT-I, indicating that phage 933W encodes the structural genes for SLT-II.
E. coli(933J) lysogens are approximately 1,000-fold more cytotoxic than E. coli(933W) lysogens (35) . Because it was possible to visualize the subunits of both SLT-I and SLT-II genes by using identical growth conditions during the minicell analysis, it is unlikely the SLT-II polypeptides were synthesized at an amount 1,000-fold less than those of SLT-I. If such were the case, the SLT-II subunits would not be visible during this analysis, even with the multicopy cloning vehicle contributing to increased toxin expression. This result suggests that quantitative differences between the amounts of SLT-I and SLT-II synthesized do not entirely explain the large differences between levels of cytotoxic activity in whole-cell lysates tested against HeLa cells. Therefore, qualitative differences between the two toxins significantly affect their relative cytotoxicity. One factor distinguishing the toxins may involve processing of the subunits.
In an effort to detect processing of the toxin subunits, we analyzed polymyxin B extractions of the toxin-positive SLT-I and SLT-II plasmids (Fig. 2) . Because the experimnentally determined molecular weights for the mature and precursor forms of the toxin subunits were in close agreement with those predicted from the DNA sequence of SLT-I (15), we interpret the gel data for the SLT-I samples as follows: (i) compared with the A precursor (32,500 molecular weight), the processed A subunit (31,500 molecular weight) migrates where the 1-lactamase precursor of pBR328 normally would be located; (ii) in the periplasmic extract of the SLT-I clone, the missing upper B subunit (9,400 molecular weight) is the unprocessed precursor form of the B subunit (7,500 molecular weight). Unlike the results for SLT-I, the comparison between the sizes of the SLT-II subunits from whole-cell lysates with those present in the polymyxin B extracts failed to detect evidence of processing of the SLT-II subunits. Because the SLT-II polypeptides seen in polymyxin B extracts are apparently the same size as those seen in the whole-cell lysates, it is unclear whether only the mature or only the precursor forms of the subunits are being Fig. 1 . In this arrangement, the A-and B-subunit genes are adjacent. The behavior of the plasmid containing the Hincll deletion suggests that transcription of A proceeds from right to left in Fig. 1 . This proposed genetic organization for SLT-II is the same as that previously described for SLT-I (14, 15, 23) .
Finally, a series of DNA-DNA hybridization reactions were conducted to further examine the relationship between the structural genes of SLT-II and those of SLT-I. These reactions were also performed to evaluate the efficacy of using internal toxin gene fragmnents as generic SLT gene probes. For these purposes, the 750-base-pair PvuII-EcoRV fragment that is internal to the coding sequence for the A subunit of SLT-1I was used to probe Southern blots of DNA samples (Fig. 3A) associated with the production of SLT-I or SLT-1I. Under conditions requiring greater than 90% homology (data not shown), the SLT-II fragment reacted only to fragments containing itself (the lower band in lane 2 and the 4.9-kb EcoRI fragment of phage 933W in lanes 1 and 5 of Fig.  3A) . Because of the similarity in sizes between the pBR328 vector fragment and the SLT-11-positive EcoRI fragment of pNN76, only a single band appears in the EcoRI digestion in Fig. 3A , lane 1. When conditions of reduced stringency requiring greater than 50% homology were used (Fig. 3B) , the probe additionally hybridized to th'e SLT-I-encoding fragments of pJN25 (NcoI-EcoRV) and of phage 933J (8.2-kb EcoRI fragment) (23 of low stringency to detect homology between VT1 sequences and previously uncharacterized VT2-associated sequences present in a 4.7-kb EcoRI fragment of phage E32511 had been reported by Willshaw et al. (37) . A more recent analysis of these VT2-encoding sequences indicates that they have a restriction map similar to that presented in Fig.  1 (36) .
The SLT-II probe was specific because it failed to hybridize with the non-toxin-related restriction fragments of phages 933J, 933W, and lambda (Fig. 3B, lanes 4, 5, and 6 , respectively). The additional reactions observed in lanes 1 and 5 are with a 2-kb portion of the toxin-associated fragment which is generated during digestion with excess amounts of EcoRI. Under conditions of low stringency, however, the SLT-II probe also reacted unexpectedly with the pBR328 fragments (Fig. 3B , the upper bands in lanes 2 and 3 plus one of the 4.9-kb bands of lane 1). Further investigation showed that both SLT-I-and SLT-II-coding sequences hybridized to sequences flanking the ampicillin resistance gene of pBR328. A comparison of SLT-I (15) and pBR328 (18) sequences revealed no primary sequence relationship between them. Instead, this comparison suggested that multiple copies of poly(dA-dT) regions are responsible for this cross hybridization reaction at reduced stringency. Although the results of our additional investigations indicate that internal DNA fragments from either SLT-I or SLT-II may not be used with confidence as generic SLT probes at low stringency, the fragments do serve as specific probes under conditions of high stringency. Because of the similarities in their genetic organization and subunit sizes, it is doubtful the hybridization observed between SLT-I and SLT-II represents the type of reaction that occurs with pBR328. Our ability to isolate the two SLT-II-producing clones from a set of 90 randomly selected transformants further supports this interpretation. Instead, these hybridizations most likely reflect the true degree of homology between SLT-I and SLT-II, estimated to be 50 to 60% (18) . Therefore, the studies presented here further support the conclusion that SLT-I and SLT-II are related toxins that have undergone considerable divergence.
